Predictions
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€37.80
13.11.21
13.11.21
€50.00
31.12.23
31.12.23
11.71%
29.06.22
29.06.22
Could be very worthwhile Investment >20% year
Catalyst Biosciences Inc
Start price
Target price
Perf. (%)
€0.78
12.11.21
12.11.21
-
12.11.22
12.11.22
1.29%
14.11.21
14.11.21
Catalyst Biosciences Inc
Start price
Target price
Perf. (%)
€0.89
12.11.21
12.11.21
-
12.11.22
12.11.22
-14.69%
15.11.21
15.11.21
Risky Investment
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.30
12.11.21
12.11.21
€0.50
12.11.22
12.11.22
-78.55%
13.11.22
13.11.22
Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€4.10
11.11.21
11.11.21
-
11.11.22
11.11.22
-3.41%
15.11.21
15.11.21
Risky Investment
Swedish Orphan Biovitrum Ab
Start price
Target price
Perf. (%)
€23.37
11.11.21
11.11.21
€28.00
11.11.22
11.11.22
-18.19%
12.11.22
12.11.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.03
11.11.21
11.11.21
€2.90
11.11.22
11.11.22
-21.78%
28.04.22
28.04.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€145.98
11.11.21
11.11.21
€75.00
11.11.22
11.11.22
-63.74%
11.04.22
11.04.22
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Nanobiotix
Start price
Target price
Perf. (%)
€8.51
11.11.21
11.11.21
€10.00
11.11.22
11.11.22
-53.17%
12.11.22
12.11.22
Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.95
11.11.21
11.11.21
€30.00
11.11.22
11.11.22
-21.68%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.19
11.11.21
11.11.21
-
11.11.22
11.11.22
2.28%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€533.60
09.11.21
09.11.21
€600.00
09.11.22
09.11.22
38.91%
10.11.22
10.11.22
Could be worthwhile Investment >10% per year
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.70
09.11.21
09.11.21
€20.00
09.11.22
09.11.22
-62.04%
09.11.22
09.11.22
Could be very worthwhile Investment >20% year
Pfizer Inc.
Start price
Target price
Perf. (%)
€41.11
09.11.21
09.11.21
€60.00
09.11.22
09.11.22
14.73%
19.01.22
19.01.22
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Invitae Corp
Start price
Target price
Perf. (%)
€20.09
09.11.21
09.11.21
€17.00
31.12.23
31.12.23
-23.92%
01.12.21
01.12.21
Could be very worthwhile Investment >20% year
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€9.23
09.11.21
09.11.21
€7.00
31.12.23
31.12.23
-56.18%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€11.19
08.11.21
08.11.21
€10.00
08.11.22
08.11.22
-52.24%
14.03.22
14.03.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Hexo Corp.
Start price
Target price
Perf. (%)
€18.34
08.11.21
08.11.21
-
08.11.24
08.11.24
-96.59%
02.06.24
02.06.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good culture
Future proof or reliable business model
